[1]
2021. The Role of Serum Level of Indoleamine 2,3–dioxygenase 1 (IDO1) in Patients with Prostate Cancer. Medico Legal Update. 21, 2 (Mar. 2021), 1402–1407. DOI:https://doi.org/10.37506/mlu.v21i2.2888.